Your browser doesn't support javascript.
loading
Context-specific regulation of cell survival by a miRNA-controlled BIM rheostat.
Labi, Verena; Peng, Siying; Klironomos, Filippos; Munschauer, Mathias; Kastelic, Nicolai; Chakraborty, Tirtha; Schoeler, Katia; Derudder, Emmanuel; Martella, Manuela; Mastrobuoni, Guido; Hernandez-Miranda, Luis R; Lahmann, Ines; Kocks, Christine; Birchmeier, Carmen; Kempa, Stefan; Quintanilla-Martinez de Fend, Leticia; Landthaler, Markus; Rajewsky, Nikolaus; Rajewsky, Klaus.
Afiliação
  • Labi V; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.
  • Peng S; Program of Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Klironomos F; Division of Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck 6020, Austria.
  • Munschauer M; Program of Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Kastelic N; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.
  • Chakraborty T; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.
  • Schoeler K; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.
  • Derudder E; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.
  • Martella M; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.
  • Mastrobuoni G; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.
  • Hernandez-Miranda LR; Program of Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Lahmann I; Division of Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck 6020, Austria.
  • Kocks C; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.
  • Birchmeier C; Program of Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Kempa S; Institute for Biomedical Ageing Research, University of Innsbruck, Innsbruck 6020, Austria.
  • Quintanilla-Martinez de Fend L; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen 72076, Germany.
  • Landthaler M; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.
  • Rajewsky N; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.
  • Rajewsky K; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.
Genes Dev ; 33(23-24): 1673-1687, 2019 12 01.
Article em En | MEDLINE | ID: mdl-31699777
Knockout of the ubiquitously expressed miRNA-17∼92 cluster in mice produces a lethal developmental lung defect, skeletal abnormalities, and blocked B lymphopoiesis. A shared target of miR-17∼92 miRNAs is the pro-apoptotic protein BIM, central to life-death decisions in mammalian cells. To clarify the contribution of miR-17∼92:Bim interactions to the complex miR-17∼92 knockout phenotype, we used a system of conditional mutagenesis of the nine Bim 3' UTR miR-17∼92 seed matches. Blocking miR-17∼92:Bim interactions early in development phenocopied the lethal lung phenotype of miR-17∼92 ablation and generated a skeletal kinky tail. In the hematopoietic system, instead of causing the predicted B cell developmental block, it produced a selective inability of B cells to resist cellular stress; and prevented B and T cell hyperplasia caused by Bim haploinsufficiency. Thus, the interaction of miR-17∼92 with a single target is essential for life, and BIM regulation by miRNAs serves as a rheostat controlling cell survival in specific physiological contexts.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Sobrevivência Celular / Regulação da Expressão Gênica no Desenvolvimento / MicroRNAs / Proteína 11 Semelhante a Bcl-2 / Hematopoese Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Sobrevivência Celular / Regulação da Expressão Gênica no Desenvolvimento / MicroRNAs / Proteína 11 Semelhante a Bcl-2 / Hematopoese Idioma: En Ano de publicação: 2019 Tipo de documento: Article